Aim: To enable Clinical Trial Networks to operate in an effective and efficient manner
- Identify critical factors to success/failure of networks, unmet needs to enhance the effectiveness and efficiency of network
- Promote linkage between networks and sharing of expertise and tools
Recent group activities:
The Efficient and Effective Clinical Trial Networks Reference Group has been creating a suite of resources and tools for clinical trials networks, based on working documents from successful, mature networks. They can be used off-the-shelf or adapted to suit.
- CTN Strategic Plan Development
- CTN Governance Structure
- CTN Membership Structure
- CTN Terms of Reference template
- CTN Executive Officer Duties
- Activities critical to success and growth of Clinical Trials Networks: Sector consultation
Current group activities:
The group continues to create resources for CTNs and is currently progressing:
- Trial Safety Oversight
- Trial Endorsement Procedure
- Publication and Authorship Policy
Latest Resources
-
-
CTN and CQR collaborations
-
ACTA Masterclass series on the Development of a Clinical Trial Network #2 – Governance
-
ACTA Masterclass series on the Development of a Clinical Trial Network #1 – Establishment of a CTN
-
ACTA Masterclass series on Development of a Clinical Trial Network #3 – Funding
-
Case study: Networking and information were key in setting up NECST
-
Case study: How the Drug and Alcohol Clinical Research and Improvement Network (DACRIN) is enhancing consumer involvement in research
-
Case study: ACTA’s crucial contribution to the growth of the Mental Health Australia General Clinical Trial Network (MAGNET)
-
Workshop: How to better develop cross-network collaborations and linkages
-
Exploring greater partnership between Clinical Trial Networks, Clinical Quality Registries and Trial Coordinating Centres with Industry – Environmental Scan
-
Activities supporting the growth of Clinical Trial Networks in Australia
-
A pilot study to prospectively estimate the health and economic return on research investment
-
Fundraising strategy: guidance for CTNs
-
Communications and marketing strategy: guidance for CTNs
-
Communications and Marketing for Clinical Trials Networks: Website content management systems (CMS)
-
Communications and Marketing for Clinical Trials Networks: Social Media
-
Communications and Marketing for Clinical Trials Networks: Email Marketing
-
Communications and Marketing for Clinical Trials Networks: Data Dashboards
-
Business Review of CTNs
-
Risk Management: Guidance for Clinical Trial Networks
-
Trial safety oversight: Guidance for Clinical Trial Networks
-
Authorship and Publication Policy: Guidance for Clinical Trial Networks
-
Stakeholder Mapping for Clinical Trial Networks
-
Trial Endorsement and Review: Guidance for CTNs
-
Clinical Trial Network Executive Officer/Network Manager Duties
-
Clinical Trial Network Committee Terms of Reference
-
Establishment of New Clinical Trial Networks: Guidance for CTNs
-
Operational Self-Assessment Tool for CTNs
-
Trial Site Metrics Tool for CTNs
-
Activities critical to success and growth of Clinical Trials Networks: Sector consultation
-
Clinical Trial Network Strategic Plan Development
-
Clinical Trial Network Membership Structures
-
Clinical Trial Network Governance Structure
Latest News
-
Workshop: National Clinical Trials Governance Framework: Update from sites that have been through accreditation
-
2023 ACTA International Clinical Trials Symposium
-
ACTA Teletrials Project – CTN and CC survey
-
Bringing together new and emerging CTNs
-
ACTA resource highlight: Trial Endorsement and Review: Guidance for CTNs
-
Sustainability; engagement; infrastructure: critical for the success of Clinical Trial Networks
-
Requests for tender
-
New resource for clinical trial networks
-
ACTA Efficient and Effective CTNs Reference Group Toolkit now available
-
Efficient and Effective CTNs – productive focus group work
-
Effective and Efficient CTNs Reference Group in sector-wide consultation